{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:52:11Z","timestamp":1787003531532,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Food and Health Bureau of the Government of the Hong Kong Special Administrative Region | Health and Medical Research Fund","doi-asserted-by":"publisher","award":["CU-16-C11"],"award-info":[{"award-number":["CU-16-C11"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473035"],"award-info":[{"award-number":["81473035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hong Kong is a high-income city with intermediate tuberculosis (TB) burden primarily driven by endogenous reactivations. A high proportion of remote latently infected people, particularly elderly, hinders the effectiveness of current strategies focusing on passive TB detection. In this study, we developed a mathematical model to evaluate the impact of treating latent TB infection (LTBI) in the elderly in addition to current TB control strategies. The model was calibrated using the annual age-stratified TB notifications from 1965\u20132013 in Hong Kong. Our results showed that at present, approximately 75% of annual new notifications were from reactivations. Given the present treatment completion rate, even if only a low to moderate proportion (approximately 20% to 40%) of elderly people were screened and treated for LTBI, the overall TB incidence could be reduced by almost 50%, to reach the 2025 milestone of the global End TB Strategy. Nevertheless, due to a high risk of hepatotoxicity in elderly population, benefit-risk ratios were mostly below unity; thus, intervention programs should be carefully formulated, including prioritising LTBI treatment for high-risk elderly groups who are closely monitored for possible adverse side effects.<\/jats:p>","DOI":"10.1038\/s41598-019-41256-4","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T17:35:28Z","timestamp":1553016928000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Mathematical modelling of the impact of treating latent tuberculosis infection in the elderly in a city with intermediate tuberculosis burden"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5610-1298","authenticated-orcid":false,"given":"Ka Chun","family":"Chong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Chiu","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Wai","family":"Yew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7238-845X","authenticated-orcid":false,"given":"Benny Chung Ying","family":"Zee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta Chun Huen","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie Haitian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8875-2415","authenticated-orcid":false,"given":"Katherine Min","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pui Hong","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Yuk Fai","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoran","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng Kiong","family":"Yeoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,19]]},"reference":[{"key":"41256_CR1","unstructured":"Department of Health, Hong Kong. Tuberculosis Manual. (2006)."},{"key":"41256_CR2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1017\/S0950268807008552","volume":"136","author":"E Vynnycky","year":"2008","unstructured":"Vynnycky, E., Borgdorff, M. W., Leung, C. C., Tam, C. M. & Fine, P. E. M. Limited impact of tuberculosis control in Hong Kong: attributable to high risks of reactivation disease. Epidemiol. Infect. 136, 943\u2013952 (2008).","journal-title":"Epidemiol. Infect."},{"key":"41256_CR3","doi-asserted-by":"publisher","first-page":"e10468","DOI":"10.1371\/journal.pone.0010468","volume":"5","author":"P Wu","year":"2010","unstructured":"Wu, P. et al. The transmission dynamics of tuberculosis in a recently developed Chinese city. PLOS ONE 5, e10468 (2010).","journal-title":"PLOS ONE"},{"key":"41256_CR4","unstructured":"Centre for Health Protection, Hong Kong. Statistics on Tuberculosis. Statistics on communicable diseases. 2017. Available at, http:\/\/www.chp.gov.hk\/en\/notifiable1\/10\/26\/43.html. (2017)."},{"key":"41256_CR5","unstructured":"Public Health England. Tuberculosis in England 2016 report. (2016)."},{"key":"41256_CR6","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1128\/JCM.41.6.2706-2708.2003","volume":"41","author":"M Chan-Yeung","year":"2003","unstructured":"Chan-Yeung, M. et al. Molecular and conventional epidemiology of tuberculosis in Hong Kong: a population-based prospective study. J. Clin. Microbiol. 41, 2706\u20132708 (2003).","journal-title":"J. Clin. Microbiol."},{"key":"41256_CR7","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/j.1532-5415.2006.00850.x","volume":"54","author":"M Chan-Yeung","year":"2006","unstructured":"Chan-Yeung, M. et al. Prevalence of tuberculous infection and active tuberculosis in old age homes in Hong Kong. J. Am. Geriatr. Soc. 54, 1334\u20131340 (2006).","journal-title":"J. Am. Geriatr. Soc."},{"key":"41256_CR8","unstructured":"World Health Organization. Implementing the end TB strategy: the essentials. 2015. Available at, http:\/\/www.who.int\/entity\/tb\/publications\/2015\/end_tb_essential.pdf?ua=1. (2017)."},{"key":"41256_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ijid.2018.05.004","volume":"72","author":"P Yap","year":"2018","unstructured":"Yap, P. et al. Prevalence of and risk factors associated with latent tuberculosis in Singapore: A cross-sectional survey. Int. J. Infect. Dis. 72, 55\u201362 (2018).","journal-title":"Int. J. Infect. Dis."},{"key":"41256_CR10","unstructured":"World Health Organization. Tuberculosis country profiles. 2018. Available at, https:\/\/www.who.int\/tb\/country\/data\/profiles\/en. (2018)."},{"key":"41256_CR11","unstructured":"Tuberculosis Surveillance Center. Tuberculosis in Japan - annual report 2017. (2017)."},{"key":"41256_CR12","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","volume":"13","author":"RM Houben","year":"2016","unstructured":"Houben, R. M. & Dodd, P. J. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLOS Med. 13, e1002152 (2016).","journal-title":"PLOS Med."},{"key":"41256_CR13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1164\/rccm.201508-1683OC","volume":"194","author":"JD Mancuso","year":"2016","unstructured":"Mancuso, J. D., Diffenderfer, J. M., Ghassemieh, B. J., Horne, D. J. & Kao, T. C. The prevalence of latent tuberculosis infection in the United States. Am. J. Respir. Crit. Care Med. 194, 501\u2013509 (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"41256_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/BF02897713","volume":"10","author":"N Ghotbi","year":"2005","unstructured":"Ghotbi, N., Nishimura, S. & Takatsuka, N. Japan\u2019s national tuberculosis control strategies with economic considerations. Environ. Health Prev. Med. 10, 213 (2005).","journal-title":"Environ. Health Prev. Med."},{"key":"41256_CR15","first-page":"7","volume":"39","author":"Centers for Disease Control and Prevention","year":"1990","unstructured":"Centers for Disease Control and Prevention. Prevention and control of tuberculosis in facilities providing long-term care to the elderly. Recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR. 39, 7\u201320 (1990).","journal-title":"Recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR."},{"key":"41256_CR16","doi-asserted-by":"crossref","unstructured":"Leung, C. C. et al. Treatment of latent infection with M. tuberculosis: update 2010. Eur. Respir. J. erj00793\u20132010 (2010).","DOI":"10.1183\/09031936.00079310"},{"key":"41256_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1378\/chest.09-0394","volume":"137","author":"CR Horsburgh Jr.","year":"2010","unstructured":"Horsburgh, C. R. Jr. et al. Latent TB infection treatment acceptance and completion in the United States and Canada. Chest 137, 401\u2013409 (2010).","journal-title":"Chest"},{"key":"41256_CR18","first-page":"1235","volume":"12","author":"Y Hirsch-Moverman","year":"2008","unstructured":"Hirsch-Moverman, Y., Daftary, A., Franks, J. & Colson, P. W. Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. Int. J. Tuberc. Lung. Dis. 12, 1235\u20131254 (2008).","journal-title":"Int. J. Tuberc. Lung. Dis."},{"key":"41256_CR19","unstructured":"Census and Statistical Department Hong Kong. Demographic Trends in Hong Kong 1981\u20132011. 2012. Available at, http:\/\/www.censtatd.gov.hk\/hkstat\/sub\/sp20.jsp?productCode=B1120017. (2017)."},{"key":"41256_CR20","unstructured":"Census and Statistical Department, Hong Kong. Hong Kong Life Tables 2009\u20132064. 2015. Available at, http:\/\/www.censtatd.gov.hk\/hkstat\/sub\/sp190.jsp?productCode=B1120016. (2017)."},{"key":"41256_CR21","unstructured":"Census and Statistical Department, Hong Kong. Hong Kong Population Projections 2015\u20132064. 2015. Available at, https:\/\/www.censtatd.gov.hk\/hkstat\/sub\/sp190.jsp?productCode=B1120015. (2017)."},{"key":"41256_CR22","doi-asserted-by":"publisher","first-page":"866","DOI":"10.5588\/ijtld.12.0573","volume":"17","author":"DW Dowdy","year":"2013","unstructured":"Dowdy, D. W., Dye, C. & Cohen, T. Data needs for evidence-based decisions: a tuberculosis modeler\u2019s \u2018wish list\u2019. Int. J. Tuberc. Lung. Dis. 17, 866\u2013877 (2013).","journal-title":"Int. J. Tuberc. Lung. Dis."},{"key":"41256_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1017\/S0950268897007917","volume":"119","author":"E Vynnycky","year":"1997","unstructured":"Vynnycky, E. & Fine, P. E. M. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol. Infect. 119, 183\u2013201 (1997).","journal-title":"Epidemiol. Infect."},{"key":"41256_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/BF00276550","volume":"22","author":"K Dietz","year":"1985","unstructured":"Dietz, K. & Schenzle, D. Proportionate mixing models for age-dependent infection transmission. J. Math. Biol. 22, 117\u2013120 (1985).","journal-title":"J. Math. Biol."},{"key":"41256_CR25","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1214\/ss\/1177011136","volume":"7","author":"A Gelman","year":"1992","unstructured":"Gelman, A. & Rubin, D. B. Inference from iterative simulation using multiple sequences. Stat. Sci. 7, 457\u2013472 (1992).","journal-title":"Stat. Sci."},{"key":"41256_CR26","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","volume":"271","author":"GA Colditz","year":"1994","unstructured":"Colditz, G. A. et al. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA. 271, 698\u2013702 (1994).","journal-title":"JAMA."},{"key":"41256_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","volume":"161","author":"DL Cohn","year":"2000","unstructured":"Cohn, D. L. et al. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am. J. Respir. Crit. Care Med. 161, 221\u2013247 (2000).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"41256_CR28","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1086\/647944","volume":"49","author":"PD Ziakas","year":"2009","unstructured":"Ziakas, P. D. & Mylonakis, E. 4 months of rifampin compared with 9 months of isoniazid for the management of latent tuberculosis infection: a meta-analysis and cost-effectiveness study that focuses on compliance and liver toxicity. Clin. Infect. Dis. 49, 1883\u20131889 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"41256_CR29","first-page":"555","volume":"60","author":"International Union Against Tuberculosis Committee on Prophylaxis","year":"1982","unstructured":"International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull. World Health Organ. 60, 555 (1982).","journal-title":"Bull. World Health Organ."},{"key":"41256_CR30","first-page":"S363","volume":"7","author":"JE Sprinson","year":"2003","unstructured":"Sprinson, J. E. et al. Evaluation of tuberculosis contact investigations in California. Int. J. Tuberc. Lung. Dis. 7, S363\u2013S368 (2003).","journal-title":"Int. J. Tuberc. Lung. Dis."},{"key":"41256_CR31","first-page":"991","volume":"117","author":"DE Kopanoff","year":"1978","unstructured":"Kopanoff, D. E., Snider, D. E. Jr. & Caras, G. J. Isoniazid-related hepatitis: a US Public Health Service cooperative surveillance study. Am. Rev. Respir. Dis. 117, 991\u20131001 (1978).","journal-title":"Am. Rev. Respir. Dis."},{"key":"41256_CR32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jtbi.2008.04.011","volume":"254","author":"S Marino","year":"2008","unstructured":"Marino, S., Hogue, I. B., Ray, C. J. & Kirschner, D. E. A methodology for performing global uncertainty and sensitivity analysis in systems biology. J. Theor. Biol. 254, 178\u2013196 (2008).","journal-title":"J. Theor. Biol."},{"key":"41256_CR33","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1093\/aje\/kwx192","volume":"186","author":"S Shrestha","year":"2017","unstructured":"Shrestha, S. et al. Impact of Targeted Tuberculosis Vaccination Among a Mining Population in South Africa: A Model-Based Study. Am. J. Epidemiol. 186, 1362\u20131369 (2017).","journal-title":"Am. J. Epidemiol."},{"key":"41256_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-017-0284-4","volume":"6","author":"J Li","year":"2017","unstructured":"Li, J. et al. The strategic framework of tuberculosis control and prevention in the elderly: a scoping review towards End TB targets. Infect. Dis. Poverty 6, 70 (2017).","journal-title":"Infect. Dis. Poverty"},{"key":"41256_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0341-4","volume":"13","author":"GH Huynh","year":"2015","unstructured":"Huynh, G. H. et al. Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation disease. BMC Med. 13, 88 (2015).","journal-title":"BMC Med."},{"key":"41256_CR36","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3201\/eid2303.161571","volume":"23","author":"J Seto","year":"2017","unstructured":"Seto, J. et al. Mycobacterium tuberculosis transmission among elderly persons, Yamagata Prefecture, Japan, 2009\u20132015. Emerg. Infect. Dis. 23, 448 (2017).","journal-title":"Emerg. Infect. Dis."},{"key":"41256_CR37","first-page":"21","volume":"89","author":"Prevention Committee of the Japanese Society for Tuberculosis, & Treatment Committee of the Japanese Society for Tuberculosis","year":"2014","unstructured":"Prevention Committee of the Japanese Society for Tuberculosis, & Treatment Committee of the Japanese Society for Tuberculosis. Treatment guidelines for latent tuberculosis infection. Kekkaku:[Tuberculosis] 89, 21 (2014).","journal-title":"Kekkaku:[Tuberculosis]"},{"key":"41256_CR38","unstructured":"World Health Organization. Global tuberculosis report 2017. (2017)."},{"key":"41256_CR39","unstructured":"World Health Organization. Guidelines on the management of latent tuberculosis infection. 2015. Available at, http:\/\/apps.who.int\/iris\/bitstream\/10665\/136471\/1\/9789241548908_eng.pdf?ua=1&ua=1. (2017)"},{"key":"41256_CR40","first-page":"27","volume":"15","author":"RA Vega","year":"1996","unstructured":"Vega, R. A., Conde, J. G. & Diaz, M. Prevalence of tuberculin reactivity and prevalence of risk factors for the development of active tuberculosis in a nursing home in Puerto Rico. P. R. Health Sci. J. 15, 27\u201331 (1996).","journal-title":"P. R. Health Sci. J."},{"key":"41256_CR41","doi-asserted-by":"publisher","first-page":"e48900","DOI":"10.1371\/journal.pone.0048900","volume":"7","author":"CC Dobler","year":"2012","unstructured":"Dobler, C. C. & Marks, G. B. Completion of treatment for latent tuberculosis infection with monthly drug dispensation directly through the tuberculosis clinic. PLOS ONE 7, e48900 (2012).","journal-title":"PLOS ONE"},{"key":"41256_CR42","doi-asserted-by":"publisher","first-page":"473","DOI":"10.5588\/ijtld.12.0697","volume":"17","author":"PW Colson","year":"2013","unstructured":"Colson, P. W. et al. Acceptance of treatment for latent tuberculosis infection: prospective cohort study in the United States and Canada. Int. J. Tuberc. Lung. Dis. 17, 473\u2013479 (2013).","journal-title":"Int. J. Tuberc. Lung. Dis."},{"key":"41256_CR43","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1164\/ajrccm.159.1.9807020","volume":"159","author":"NN Bock","year":"1999","unstructured":"Bock, N. N., Metzger, B. S., Tapia, J. R. & Blumberg, H. M. A tuberculin screening and isoniazid preventive therapy program in an inner-city population. Am. J. Respir. Crit. Care Med. 159, 295\u2013300 (1999).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"41256_CR44","unstructured":"Public Health England. Tuberculosis in England 2017 report (presenting data to end of 2016); 2017. Available at, https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/686185\/TB_Annual_Report_2017_v1.1.pdf. (2018)."},{"key":"41256_CR45","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1056\/NEJMoa1714283","volume":"379","author":"D Menzies","year":"2018","unstructured":"Menzies, D. et al. Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults. N. Engl. J. Med. 379, 440\u2013453 (2018).","journal-title":"N. Engl. J. Med."},{"key":"41256_CR46","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jval.2012.09.006","volume":"16","author":"M Sadatsafavi","year":"2013","unstructured":"Sadatsafavi, M. et al. A quantitative benefit-risk analysis of isoniazid for treatment of latent tuberculosis infection using incremental benefit framework. Value Health 16, 66\u201375 (2013).","journal-title":"Value Health"},{"key":"41256_CR47","unstructured":"Centre for Health Protection Hong Kong. Antimicrobial resistance profiles of Mycobacterium tuberculosis. Statistics on laboratory surveillance, Antimicrobial susceptibility testing. 2017, Available at, http:\/\/www.chp.gov.hk\/en\/data\/1\/10\/641\/695\/4844.html. (2017)"},{"key":"41256_CR48","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1164\/ajrccm\/145.1.36","volume":"145","author":"Hong Kong Chest Service\/Tuberculosis Research Centre, Madras\/British Medical Research Council","year":"1992","unstructured":"Hong Kong Chest Service\/Tuberculosis Research Centre, Madras\/British Medical Research Council. A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Am. Rev. Respir. Dis. 145, 36\u201341 (1992).","journal-title":"Am. Rev. Respir. Dis."},{"key":"41256_CR49","unstructured":"Leung, E. C. C. et al. Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city. Eur. Respir. J. erj00712\u20132012 (2012)."},{"key":"41256_CR50","unstructured":"Department of Health, Hong Kong. Annual report 1949\u20132013 tuberculosis & chest service. (2013)."},{"key":"41256_CR51","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1164\/rccm.200909-1355OC","volume":"182","author":"CR Horsburgh Jr.","year":"2010","unstructured":"Horsburgh, C. R. Jr. et al. Revisiting rates of reactivation tuberculosis: a population-based approach. Am. J. Respir. Crit. Care Med. 182, 420\u2013425 (2010).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"41256_CR52","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1098\/rsif.2006.0193","volume":"4","author":"T Cohen","year":"2006","unstructured":"Cohen, T., Colijn, C., Finklea, B. & Murray, M. Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission. J. R. Soc. Interface 4, 523\u2013531 (2006).","journal-title":"J. R. Soc. Interface"},{"key":"41256_CR53","first-page":"3","volume":"11","author":"C Tam","year":"2006","unstructured":"Tam, C. The DOTS Strategy in Hong Kong. Hong Kong Med. Diary 11, 3\u20134 (2006).","journal-title":"Hong Kong Med. Diary"},{"key":"41256_CR54","first-page":"83","volume":"9","author":"CM Tam","year":"2003","unstructured":"Tam, C. M., Leung, C. C., Noertjojo, K., Chan, S. L. & Chan-Yeung, M. Tuberculosis in Hong Kong-patient characteristics and treatment outcome. Hong Kong Med. J. 9, 83\u201390 (2003).","journal-title":"Hong Kong Med. J."},{"key":"41256_CR55","first-page":"443","volume":"9","author":"MY Wong","year":"2005","unstructured":"Wong, M. Y., Leung, C. C., Tam, C. M. & Lee, S. N. Directly observed treatment of tuberculosis in Hong Kong. Int. J. Tuberc. Lung. Dis. 9, 443\u2013449 (2005).","journal-title":"Int. J. Tuberc. Lung. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41256-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41256-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41256-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T02:47:34Z","timestamp":1671245254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41256-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,19]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["41256"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-41256-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,19]]},"assertion":[{"value":"6 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"4869"}}